Chemicals M&A in Transition (Y&P article in ICIS Chemical Business, June 14-20, 2019)news2021-07-01T19:07:02+00:00June 14th, 2019|Our Publications|
M&A Values Hold Strong But Volume Dips (Chemweek March 11-18, 2019)news2021-07-01T19:07:00+00:00May 11th, 2019|Our Publications|
Chemicals M&A at Inflection Point (Y&P article in ICIS March 1-7, 2019 issue)news2021-07-01T19:07:08+00:00March 1st, 2019|Our Publications|
CFIUS Reform’s Impact on Biopharma (Phama Exec February 2019 issue)news2021-07-01T19:07:13+00:00February 1st, 2019|Our Publications|
Chemical Week – Young & Partners M&A Interview (Nov 5, 2018 issue)news2021-07-01T19:07:18+00:00November 5th, 2018|Our Publications|
Good, bad news for Chemical Financing (Y&P article in ICIS Chemical Business) Nov 2 – Nov 8, 2018 issuenews2021-07-01T19:07:25+00:00November 2nd, 2018|Our Publications|
Business Check – Industry Financial Pulse (Young & Partners article in Pharm Exec Nov 2018)news2021-07-01T19:07:30+00:00November 1st, 2018|Our Publications|
Chemical M&A – Reality vs Myth (Y&P article in ICIS Chemical Business) Oct 26 – Nov 1, 2018 issuenews2021-07-01T19:10:05+00:00October 26th, 2018|Our Publications|
The Rise of China Biopharma (Pharmaceutical Executive – July issue)news2021-07-01T19:10:00+00:00July 1st, 2018|Our Publications|
Dr. Spielberg, former Deputy Commissioner of the FDA, joins Young & Partners (June 11, 2018)news2021-07-01T19:09:54+00:00June 11th, 2018|Our Publications|
